| DB ID | MyCo_3861 |
| Title | Coexistence of allergic bronchopulmonary aspergillosis and atopic dermatitis: is total IgE level useful to identify relapses of allergic bronchopulmonary aspergillosis? |
| Year | 2012 |
| PMID | 23026291 |
| Fungal Diseases involved | Allergic bronchopulmonary aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | Atopic dermatitis |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | The authors declare that the procedures followed were in accordance with the regulations of the responsible Clinical Research Ethics Committee and in accordance with those of the Worl Medical Association and the Helsinki Declaration. |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Total IgE |
| Biomarker Full Name | Total Immunoglobulin E |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | None |
| Cohort | A 49-year-old woman who had suffered from AD for 20 years and asthma for four years was admitted to our outpatient clinic because of uncontrolled asthma. |
| Cohort No. | 1 |
| Age Group | 49 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Immunofluorescence |
| Technique | Immunoassay |
| Analysis Method | IgE measurement assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | IgE measurement assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
